1. Home
  2. NERV vs STFS Comparison

NERV vs STFS Comparison

Compare NERV & STFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NERV
  • STFS
  • Stock Information
  • Founded
  • NERV 2007
  • STFS 2015
  • Country
  • NERV United States
  • STFS China
  • Employees
  • NERV N/A
  • STFS N/A
  • Industry
  • NERV Biotechnology: Pharmaceutical Preparations
  • STFS
  • Sector
  • NERV Health Care
  • STFS
  • Exchange
  • NERV Nasdaq
  • STFS NYSE
  • Market Cap
  • NERV 10.7M
  • STFS 10.8M
  • IPO Year
  • NERV 2014
  • STFS 2024
  • Fundamental
  • Price
  • NERV $1.61
  • STFS $1.00
  • Analyst Decision
  • NERV Hold
  • STFS
  • Analyst Count
  • NERV 1
  • STFS 0
  • Target Price
  • NERV $5.00
  • STFS N/A
  • AVG Volume (30 Days)
  • NERV 15.1K
  • STFS 1.2M
  • Earning Date
  • NERV 04-30-2025
  • STFS 02-14-2025
  • Dividend Yield
  • NERV N/A
  • STFS N/A
  • EPS Growth
  • NERV N/A
  • STFS 43.38
  • EPS
  • NERV 0.19
  • STFS 0.15
  • Revenue
  • NERV N/A
  • STFS $14,972,726.00
  • Revenue This Year
  • NERV N/A
  • STFS N/A
  • Revenue Next Year
  • NERV N/A
  • STFS N/A
  • P/E Ratio
  • NERV $8.95
  • STFS $6.68
  • Revenue Growth
  • NERV N/A
  • STFS 57.60
  • 52 Week Low
  • NERV $1.42
  • STFS $0.80
  • 52 Week High
  • NERV $3.69
  • STFS $17.91
  • Technical
  • Relative Strength Index (RSI)
  • NERV 41.00
  • STFS N/A
  • Support Level
  • NERV $1.54
  • STFS N/A
  • Resistance Level
  • NERV $1.89
  • STFS N/A
  • Average True Range (ATR)
  • NERV 0.11
  • STFS 0.00
  • MACD
  • NERV 0.00
  • STFS 0.00
  • Stochastic Oscillator
  • NERV 22.68
  • STFS 0.00

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

About STFS STAR FASHION CULTURE HOLDINGS LIMITED

Star Fashion Culture Holdings Ltd is a content marketing solutions services provider. The company offer services focusing on marketing campaign planning and execution, offline advertising services; and online precision marketing services. The services also include marketing campaign planning and execution, events including marathons, sports events, and music festivals.

Share on Social Networks: